Veru Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
Good afternoon, everyone, and welcome to another session here on the second day of Oppenheimer's Virtual Fall Healthcare Summit. We are very delighted to have Veru Pharma with us for this session. If you follow our research, you'll know that we not only cover the stock with an outperform rating, but really see this as a top pick within our universe.
On behalf of the Company, we have Founder and CEO, Dr. Mitch Steiner, who will be walking us through all the various programs that the Company is pursuing. And if you have any questions, please submit to us through the online platform, and I'll do my best to ask those. And with that, I'll turn it over to Mitch.
Great. Thank you. Thank you, Leland, and thank you to Oppenheimer for inviting us to your investment conference. So Veru is an oncology biopharmaceutical company, and we are focused on prostate cancer, breast cancer, but we're much more than that. Before I begin, I will be making some forward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
